Correction: Repository-based plasmid design.

Autor: Timmons JJ, Densmore D

Publikováno v: PloS one [PLoS One] 2020 Feb 27; Vol. 15 (2), pp. e0229981. Date of Electronic Publication: 2020 Feb 27 (Print Publication: 2020).

Literature Review of Spinal Cord Glioblastoma.

Autor: Timmons JJ; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology., Zhang K; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology., Fong J; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology., Lok E; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology., Swanson KD; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology., Gautam S; Biostatistics Section, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA., Wong ET; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology.

Publikováno v: American journal of clinical oncology [Am J Clin Oncol] 2018 Dec; Vol. 41 (12), pp. 1281-1287.

Tumor treating fields for newly diagnosed high‐grade glioma based on the criteria of 2021 WHO CNS5: A retrospective analysis of Chinese patients in a single center.

Autor: Zhang, Li¹ (AUTHOR), Ren, Yanming² (AUTHOR), Peng, Youheng² (AUTHOR), Luo, Yong¹ (AUTHOR), Liu, Yanhui² (AUTHOR), Wang, Xiang² (AUTHOR), Yang, Yuan² (AUTHOR), Liu, Lei¹ (AUTHOR), Ai, Ping¹ (AUTHOR), Yang, Xiaoyan¹ (AUTHOR), Li, Yanchu¹ (AUTHOR), Mao, Qing² (AUTHOR) qingmao2000@163.com, Wang, Feng¹ (AUTHOR) wangfeng5024@126.com

Publikováno v: Cancer Medicine. Jun2024, Vol. 13 Issue 11, p1-11. 11p.

Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.

Autor: Patnaik A; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts. apatnaik1@uchicago.edu.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Swanson KD; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Csizmadia E; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Solanki A; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts., Landon-Brace N; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts., Gehring MP; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Laboratório de Farmacologia Aplicada, PUCRS, Porto Alegre, Brazil., Helenius K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Olson BM; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Pyzer AR; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts., Wang LC; Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Elemento O; Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Novak J; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Thornley TB; Transplant Institute and Immunology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Montaser L; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Timmons JJ; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Morgan TM; Department of Urology, University of Michigan, Ann Arbor, Michigan., Wang Y; Department of Urology, University of Michigan, Ann Arbor, Michigan., Levantini E; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts.; Institute of Biomedical Technologies, National Research Council (CNR), Pisa, Italy., Clohessy JG; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Preclinical Murine Pharmacogenetics Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Kelly K; Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, Maryland., Pandolfi PP; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Rosenblatt JM; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Avigan DE; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Ye H; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Karp JM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Balk SP; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Cantley LC; Meyer Cancer Center, Weill Cornell Medical College, New York, New York.

Publikováno v: Cancer discovery [Cancer Discov] 2017 Jul; Vol. 7 (7), pp. 750-765. Date of Electronic Publication: 2017 Mar 08.

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.

Autor: Timmons JJ; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology, Beth Israel Deaconess Medical Center & Harvard Medical School., Cohessy S; Division of Cancer Genetics, Department of Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School., Wong ET; Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology, Beth Israel Deaconess Medical Center & Harvard Medical School; ewong@bidmc.harvard.edu.

Publikováno v: Journal of visualized experiments : JoVE [J Vis Exp] 2016 May 24 (111). Date of Electronic Publication: 2016 May 24.